An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1
DOI:
https://doi.org/10.25557/2310-0435.2022.03.81-82Keywords:
NeuroimmunopathologyAbstract
Conference abstract
Downloads
Published
2022-10-14
Issue
Section
Brief reports
How to Cite
An alkanecarboxylic acid derivative in the correction of immunopathological disorders in patients with multiple sclerosis associated with the activation of the human endogenous retrovirus HERV-E λ 4-1. (2022). Patogenez (Pathogenesis), 20(3), 81-82. https://doi.org/10.25557/2310-0435.2022.03.81-82